Background: This study identifies the effects of gall stone on the risks of developing renal stone in a nationwide cohort study. Aim: Studies on the association between gall stone and renal stone are scarce. Methods: We identified patients with gallstones using the catastrophic illness registry of the Taiwan National Health Insurance Research Database (NHIRD). We selected a comparison cohort, random frequency-matched by age, sex and index year, from the general population. We analyzed the risk of renal stones by using Cox proportional hazards regression models for sex, age and comorbidities. Results: Of the 23.74 million people in the database, we followed 25 258 gallstone patients (54.5% female) and 101 029 control patients. The risk of
developing renal stones was 1.68-fold greater in gallstone patients, compared with patients without gallstones after adjusting for age, sex and comorbidities. The substantially increased risk of renal stones was also significant in gallstone patients regardless of comorbidities. In the follow-up period <1 year, the adjusted hazard ratio was 2.51 (95% CI = 2.25-2.80) compared to non-gallstone group. The cumulative incidence of renal stone in the gallstone group was higher than in the non-gallstone group (P < 0.0001, in the log-rank test). Conclusion: This nationwide cohort study demonstrates that the risk of renal stones is significantly higher in gallstone patients, compared with the general population. This study provides information to enable physicians to implement adequate prevention measures to decrease both stones formation.
What's already known about this topic?
(i) Both gallstone and renal stone are highly prevalent.
(ii) Whether they share a pathophysiological mechanism remains unclear.
What does this article add?
(i) This nationwide cohort study demonstrates that the risk of renal stones is significantly higher in gallstone patients. (ii) To enable physicians to implement adequate prevention measures to decrease both stones formation.
Introduction
Gallstones are common in the general population. The national prevalence of gallstones varies between 0.1% and 61.5% worldwide. 1 The prevalence in Taiwan was 10.7%. 2 Incidence increases with age and patients are predominantly female. Gallstones particularly affect premenopausal women.
Gallstones can be divided into two major types: cholesterol stones and pigment stones. Unlike in Western countries, pigment stones are prevalent in Asia. 3, 4 Gallstones can be silent or accompanied by various clinical problems, such as biliary colic, cholecystitis, obstructive jaundice and pancreatitis. They are a leading cause of emergency department visits and hospital admission for gastrointestinal problems. 4, 5 Renal stones are also common, and national prevalence varies globally between 2% and 20%. [6] [7] [8] In Asia, the prevalence of renal stones varies between 1% and 5%. 9 Unlike gallstones, renal stones are more prevalent among men than women. 10 Recurrent stone formation is also a serious problem, and the incidence of renal stone recurrence within 10 years has been found to be as high as 50%.
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Both stones are highly prevalent. They are prominent public health issues and substantially increase the economic burden on national health insurance. 12, 13 Whether they share a pathophysiological mechanism remains unclear.
Taiwan initiated its National Health Insurance (NHI) program in 1995, and the data available from this program offer a unique opportunity for research. In this study, we used a 13-year nationwide population-based dataset to determine the relationship between gallstones and renal stones.
Materials and methods

Data source
The Taiwan Department of Health consolidated 13 insurance programs into the NHI program in March 1995. More than 99% of the population of Taiwan has been covered by the program since 2000. We obtained a data subset from the National Health Insurance Research Database (NHIRD) established by the National Health Research Institutes (NHRI), which is authorized to manage the insurance data. This dataset consists of claims data collected from 1 million people randomly selected from the total population of insurant in the 1996-2010 period. Information on the demographic status of insured individuals and claims data for inpatient and outpatient care were available in the dataset. Personal information was scrambled to protect privacy.
Patient diagnoses were coded using the International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM). We ensured that all data were deidentified and analyzed anonymously. This study was exempted from full ethical review by the institutional review board of China Medical University (CMU-REC-101-012).
Study population
Using the population-based claims data from 1996 to 2010, we identified 25 258 new gallstone (ICD-9-CM code 574) patients the first-time gallstone diagnosis served as the index year from 1998 to 2008. The gallstone patients (N = 25 258) are classified according to ICD-9-CM. If the ICD-9-CM is 574.0, 574.1, 574.3, 574.4, 574.6, 574.7 and 574.8 were classified in group with cholecystitis (n = 10 778, 42.7%) (symptomatic). The ICD-9-CM coding is 574.2, 574.5 and 574.9 were classified in group without cholecystitis (n = 14 480, 57.3%) (asymptomatic). For comparison, we randomly selected 101 029 individuals without gallstones at a ratio of 1:4, frequency-matched by sex, age and index year. Gallstone diagnosis dates were designated as index dates to enable the measurement of follow-up person-years. The follow-up person-years at the end of 2010 were calculated for each participant until the diagnosis of renal stone, withdrawal from the insurance system, censored because of death, or loss to follow-up. People with a history of gallstones at the baseline were excluded from the study. Comorbidities that may have an association with renal stones (ICD-9-CM code 592) were also identified, including diabetes (ICD-9-CM codes 250), hypertension (ICD-9-CM codes 401-405), hyperlipidemia (ICD-9-CM codes 272), hyperparathyroidism (ICD-9-CM 252.0, 252.1, 252.2, 252.8), urinary tract infection (UTI; ICD-9-CM 599, 595.0, 595.2, 590.0, 590.1, 590.11, 590.8, 590.81), gout (ICD-9-CM 274), Crohn's disease (ICD-9-CM 555.0-555.2), liver cirrhosis (ICD-9-CM 571) and obesity (ICD-9-CM 278.0).
Statistical analysis
We compared the distributions of age, sex and comorbidities between the gallstone and nongallstone groups by using the Chi-squared test. The incidence of renal stones was estimated using age, sex and comorbidity for both cohorts. The incidence rate ratio of renal stones in the gallstone and nongallstone cohorts was measured for these variables by using Poisson regression analysis.
Multivariable Cox proportional hazards model was used to compare the adjusted hazard ratios (HRs) of renal stones between the gallstone cohort and the non-gallstone cohort at a 95% confidence interval (CI), controlling for sex, age and comorbidities for adjustment. We performed these statistical analyses by using the SAS 9.3 statistical package (SAS Institute Inc., NC, USA), with P < 0.05 in twotailed tests considered significant. We used R software (R Foundation for Statistical Computing, Vienna, Austria) to conduct a Kaplan-Meier analysis to measure the cumulative renal stone incidence for both study groups, and used the log-rank test to assess the differences between the two cumulative incidence curves. Table 1 compares the demographic characteristics and comorbidities of the gallstone (N = 25 258) and non-gallstone groups (N = 101 029). Both groups had similar distributions of sex and age, and were predominantly female (54.5%) and 35-65 years of age (54.8%). Mean age in gallstone group is 55.9 (SD: 16.9), and in non-gallstone group is 55.4 (SD: 17.1). Diabetes, hypertension, hyperlipidemia, hyperparathyroidism, UTI, gout, Crohn's disease, liver cirrhosis and obesity were more prevalent in the gallstone group at the baseline (P < 0.05).
Results
In Table 2 , we analyzed the interaction between gallstone and comorbidity. We found that only liver cirrhosis had the interaction with gallstone (P = 0.0253). The overall incidence of renal stones was 1.79-fold higher in the gallstone group than in the non-gallstone group (13.03 vs. 7.29 per 1000 person-years). The corresponding adjusted HR was 1.68 (95% CI = 1.59-1.77), assessed using multivariable Cox proportional hazards regression analysis (Table 3 ). The incidence was higher in men than in women. The age-specific analysis showed that incidence of renal stones increased with age in both groups. However, the adjusted HR was higher in gallstone patients aged < 35 years (adjusted HR = 2.01, 95% CI = 1.66-2.42) than in those aged 35-65 years (adjusted HR = 1.59, 95% CI = 1.49-1.70) and 65 years and older (adjusted HR = 1.76, 95% CI = 1.59-1.94). Renal stone incidence estimated for patients with liver cirrhosis was slightly higher than that in patients without liver cirrhosis. By the end of the follow-up period, the cumulative incidence of renal stones was 5.0% higher in the gallstone group than in the non-gallstone group (13.0% vs. 8.0%) (Figure 1 ). Table 4 shows that the incidence rate ratio of the gallstone group to the non-gallstone group declined slightly with time. The adjusted HR declined from 2.51 (95% CI = 2.25-2.80) at the 1-year follow-up to 1.42 (95% CI = 1.28-1.57) after 5 years or more.
Discussion
This nationwide population-based retrospective cohort study evaluated the relationship between gallstones and renal stones in Taiwan. In an early cross-sectional study, Akoudad et al.
14 indicated that kidney stone disease is related to gallstones in African-Americans. In another cross-sectional prospective study, Taylor et al. 15 reported that both stone diseases are independently related in woman group and men group. Because we used data from the NHI system, which covers more than 99% of the population of Taiwan, the results can be generalized. We observed that the overall incidence rate of renal stones was 79% higher in the gallstone cohort than in the non-gallstone cohort, with an adjusted HR of 1.68 in the following 13 years. We suggest, therefore, that gallstones increase the risk of developing renal stones.
Gallstones are common and include inalterable risk factors, including age, sex, ethnicity and gene factors.
1 Some conditions also contribute to the development, including liver cirrhosis and Crohn's disease. 1 The prevalence of renal stones is higher in men than in women. 16 The risk of renal stone development can be averted by diet and lifestyle changes. 17 Medical problems such as recurrent urinary tract infection, hyperparathyroidism and metabolic disease also promote the formation of renal stone. 18 The reason gallstones predict the development of renal stones is not well documented, but hypotheses have been proposed. Obesity is a critical risk factor for gallstone formation because it influences the function of hepatic cells and affects the secretion of cholesterol. 4, 19, 20 The risk magnitude is greater in women than in men and is high in patients with youth-onset obesity. 1 The presence of central obesity is more related to the risk of gallstones than merely a high BMI. 21 Diabetes influences cholelithiasis but is not an independent factor. 22 Hyperlipidemia is another risk that has been identified in Taiwan 22 but not in Western countries. 23 Recent studies have indicated that obesity exerts a systemic effect on the function of the kidneys and promotes the formation of renal stones, mainly uric acid and infection stones. 17, 24, 25 Diabetes predicts the formation of uric acid stones but not calcium stones. 26, 27 Renal stone formation in certain patients may be explained by the effect of these conditions on the insulin-signaling pathway. 26 We suggest that metabolic changes influence stone formation, both in the gallbladder and in the kidneys. Our study revealed that gallstone patients have a higher rate of metabolism-related comorbidities (e.g. diabetes, hyperlipidemia and hypertension). The role of hypertension has not been identified by previous studies.
Gallbladder wall inflammation is a critical factor promoting the formation of stones. 28 Infection by bacteria in the genus Helicobacter may account for this, but the role infection plays must be identified. Brown pigment stones containing calcium salts of unconjugated bilirubin and cholesterol are related to bacterial or parasitical infection of the bile ducts. 28 Bacteria release substances that increase levels of unconjugated bilirubin and bile acid, resulting in stone formation. Infections also play a role in the formation of renal stones because they influence urine alkylation. The leading pathogens are Proteus and Staphylococcus aureus.
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These can influence the breakdown of urea and affect the acid-base status of urine. Based on these data, infection and inflammation might play a critical role in stone formation. However, the correlation between these two types of stone is unclear.
Crohn's disease has been associated with both stones. 30, 31 This is likely because the condition interrupts bile acid absorption and disturbs the enterohepatic cycling of bilirubin, increasing the formation of cholesterol stones and pigment stones. 28, 32 It also facilitates an increase in urine oxalate, promoting the formation of calciumcontaining stones. 33 The gastrointestinal system is a major site for calorie, electrolyte and fluid absorption. It is speculated that these factors influencing intestinal absorption and circulation increase the risk of stone diseases.
To avoid falsely determining a high renal stone prevalence because of incidental image finding during gallstone examination, we used time-lag analysis to prevent detection bias. Table 4 shows that Multiple analysis including age, sex and comorbidities. ***p < 0.001. prevalence was highest in the first year and decreases gradually in the following years. Using multivalent analysis, the adjusted HR within the first year was 2.51 (95% CI = 2.25-2.80), 1.56 within 1-3 years, 1.54 within 3-5 years and 1.42 at the 5-year follow-up. This study has certain limitations. Because the data were obtained from the NHI system, we were unable to evaluate the influence of lifestyle risk factors, including diet, lifestyle and activity levels. We were also unable to analyze family history or genetics. In addition, the database does not contain the data about BMI or waistline measurements, stone components, major components of the metabolic syndrome, or urine samples for further analysis. Finally, gallstone disease is a frequent condition and gallbladder stones are clinically silent in the majority of cases. Thus, at least theoretically, a critical amount of subjects included in the nongallstone cohort group might have asymptomatic gallstones. Further study is required to evaluate the influence of these factors on gallstones and renal stones.
Conclusion
In conclusion, our data provide evidence that the risk of developing renal stones is higher among people with gallstones than among the general population. Because of the high recurrence rate of renal stones, being aware of the appearance of early symptoms and signs is crucial. This study provides information to enable physicians to implement adequate prevention measures to decrease stone formation.
